Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22773551 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Capecitabine;   Drug: Erlotinib

Study has passed its completion date and status has not been verified in more than two years.